knockout serum replacement drug
Evidence from:
primary |
all sources
Related entities (2)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| DMEM/F12 | associated_with | knockout serum replacement | — | 1 |
| hiPSC lines | associated_with | knockout serum replacement | — | 1 |
Mentioned in (7)
Papers in which this entity is mentioned.
- LINE-1 retrotransposons mediate cis-acting transcriptional control in human pluripotent stem cells and regulate early brain development. (2025)
- A Compendium of Mutational Signatures of Environmental Agents. (2019)
- Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. (2018)
- Efficient derivation of microglia-like cells from human pluripotent stem cells. (2016)
- Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes. (2016)
- Establishment of human iPSC-based models for the study and targeting of glioma initiating cells. (2016)
- Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. (2012)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| knockout serum replacement | drug | 7 | 8 |